1-5 of 5
Yuuri Hashimoto
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Hypoxia-Driven Mechanism of Vemurafenib Resistance in Melanoma

Yong Qin, Jason Roszik, Chandrani Chattopadhyay, Yuuri Hashimoto, Chengwen Liu, Zachary A. Cooper, Jennifer A. Wargo, Patrick Hwu, Suhendan Ekmekcioglu, Elizabeth A. Grimm
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2016) 15 (10): 2442–2454.
https://doi.org/10.1158/1535-7163.MCT-15-0963
Published: 02 October 2016
View article titled, Hypoxia-Driven Mechanism of Vemurafenib Resistance in Melanoma
Open the PDF for Hypoxia-Driven Mechanism of Vemurafenib Resistance in Melanoma in another window
Includes: Supplementary data
Journal Articles

Targeted Photodynamic Virotherapy Armed with a Genetically Encoded Photosensitizer

Kiyoto Takehara, Hiroshi Tazawa, Naohiro Okada, Yuuri Hashimoto, Satoru Kikuchi, Shinji Kuroda, Hiroyuki Kishimoto, Yasuhiro Shirakawa, Nobuhiro Narii, Hiroyuki Mizuguchi, Yasuo Urata, Shunsuke Kagawa, Toshiyoshi Fujiwara
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2016) 15 (1): 199–208.
https://doi.org/10.1158/1535-7163.MCT-15-0344
Published: 07 January 2016
View article titled, Targeted Photodynamic Virotherapy Armed with a Genetically Encoded Photosensitizer
Open the PDF for Targeted Photodynamic Virotherapy Armed with a Genetically Encoded Photosensitizer in another window
Includes: Multimedia, Supplementary data
Journal Articles

Dual Programmed Cell Death Pathways Induced by p53 Transactivation Overcome Resistance to Oncolytic Adenovirus in Human Osteosarcoma Cells

Joe Hasei, Tsuyoshi Sasaki, Hiroshi Tazawa, Shuhei Osaki, Yasuaki Yamakawa, Toshiyuki Kunisada, Aki Yoshida, Yuuri Hashimoto, Teppei Onishi, Futoshi Uno, Shunsuke Kagawa, Yasuo Urata, Toshifumi Ozaki, Toshiyoshi Fujiwara
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (3): 314–325.
https://doi.org/10.1158/1535-7163.MCT-12-0869
Published: 10 March 2013
View article titled, Dual Programmed Cell Death Pathways Induced by p53 Transactivation Overcome Resistance to Oncolytic Adenovirus in Human Osteosarcoma Cells
Open the PDF for Dual Programmed Cell Death Pathways Induced by p53 Transactivation Overcome Resistance to Oncolytic Adenovirus in Human Osteosarcoma Cells in another window
Includes: Supplementary data
Journal Articles

Preclinical Evaluation of Differentially Targeting Dual Virotherapy for Human Solid Cancer

Ryo Sakai, Shunsuke Kagawa, Yasumoto Yamasaki, Toru Kojima, Futoshi Uno, Yuuri Hashimoto, Yuichi Watanabe, Yasuo Urata, Noriaki Tanaka, Toshiyoshi Fujiwara
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2010) 9 (6): 1884–1893.
https://doi.org/10.1158/1535-7163.MCT-10-0205
Published: 09 June 2010
View article titled, Preclinical Evaluation of Differentially Targeting Dual Virotherapy for Human Solid Cancer
Open the PDF for Preclinical Evaluation of Differentially Targeting Dual Virotherapy for Human Solid Cancer in another window
Includes: Supplementary data
Journal Articles

Preclinical evaluation of synergistic effect of telomerase-specific oncolytic virotherapy and gemcitabine for human lung cancer

Dong Liu, Toru Kojima, Masaaki Ouchi, Shinji Kuroda, Yuichi Watanabe, Yuuri Hashimoto, Hideki Onimatsu, Yasuo Urata, Toshiyoshi Fujiwara
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (4): 980–987.
https://doi.org/10.1158/1535-7163.MCT-08-0901
Published: 16 April 2009
View article titled, Preclinical evaluation of synergistic effect of telomerase-specific oncolytic virotherapy and gemcitabine for human lung cancer
Open the PDF for Preclinical evaluation of synergistic effect of telomerase-specific oncolytic virotherapy and gemcitabine for human lung cancer in another window
Includes: Supplementary data